HealthNotableConfirmedDeveloping
5.9
Gene-editing therapy demonstrates sustained LDL cholesterol reduction in one-year clinical trial
New York Times·US·1 day ago
Public health outcomes for cardiovascular disease are currently constrained by low patient adherence to existing drug therapies and limited access to advanced treatments. The report highlights that systemic improvements in medication accessibility are necessary to reduce the incidence of heart attacks and strokes.